Sonographic evaluation of schistosomiasis mansoni by D'Ippolito, Giuseppe
VRadiol Bras. 2013 Jan/Fev;46(1):V–VI
EDITORIAL
According to data from the Brazilian Ministry of Health, schis-
tosomiasis is a worldwide endemic disease present in 52 coun-
tries and in 19 Brazilian states. About 200 million people around
the world are affected by this disease(1). In Brazil, estimates di-
verge about its prevalence(2), ranging between 2.5 and 8 million
people with the disease(3). Since 1975, with the creation of the
Programa Especial de Controle da Esquistossomose (PECE) (Spe-
cial Program for Schistosomiasis Management) introducing che-
motherapy and sanitary measures, the number of people with
this disease has decreased, according data from the Ministry of
Health. Even so, the number of schistosomiasis patients is still
considerably high in our country(3).
The morbimortality associated with schistosomiasis mansoni
(SM) is related to the degree of hepatic fibrosis which, on its turn,
induces portal hypertension, collateral circulation and higher risks
for bleeding(4–6). Since the eighties, ultrasonography (US) has been
playing a critical role in the diagnosis of abdominal alterations
related to SM, determining the degree of periportal fibrosis and
portal hypertension, as well as identifying their associated com-
plications(4–7). Most recently, studies have demonstrated that
magnetic resonance imaging (MRI) can contribute to a noninvasive
evaluation of such patients(1,8) and to the differentiation between
SM and hepatic cirrhosis(9), although US remains as the main
diagnostic tool because of its wide availability and low cost(10).
Despite the wide utilization of US, some limitations – among
others, the one related to reproducibility –, have been attributed
to the method(8). However, most recently it was demonstrated that
US presents a high agreement in the evaluation of patients with
portal hypertension(11), reinforcing its utility amongst SM patients.
For such reasons, the article written by Fernandes et al.(12),
published in the present issue of Radiologia Brasileira is wel-
come. In such a study, researchers from Universidade Federal de
Sergipe (UFS) have evaluated sonographic findings in 89 patients
with chronic clinical presentations of SM, from an endemic re-
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gion and from the University Hospital of UFS, with the objective
of establishing an association between imaging findings proposed
by the World Health Organization (WHO)(13) and the disease
morbidity. The authors have concluded that the sonographic pro-
tocol adopted by the WHO can detect advanced periportal fibrosis
in patients with severe disease, with higher sensitivity than other
methods alone such as measurement of the periportal space for
example. Such findings corroborate the value of a comprehen-
sive assessment of SM patients, including the determination of
the portal fibrosis extent, presence of portal hypertension (by means
of measurements of portal and splenic veins calibers and pres-
ence of collateral circulation), and sonographic organometry. On
the other hand, the study has found the low sensitivity of the
method for detecting periportal fibrosis in patients with
hepatosplenic schistosomiasis mansoni from endemic regions and
possibly resulting from milder disease presentations, maybe in-
dicating the limited capacity of US to detect earlier stages of peri-
portal fibrosis. Some studies have demonstrated a low intermethod
agreement between US and MRI (considered as the most effec-
tive noninvasive method in the assessment of periportal fibrosis)
in the evaluation of mild degrees of periportal fibrosis(14,15), jus-
tifying the results observed by Fernandes et al.
The main objective of the programs for schistosomiasis man-
agement is to reduce the disease morbidity. For this to happen,
an accurate knowledge of the stage of disease in determined group
of patients is imprescindible in such a context for preventing
possible complications and allowing a prompt adoption of the most
appropriate approach. Studies like the one developed by Fernandes
et al. allow the confirmation the method usefulness, the recogni-
tion of some of its limitations as well as encourage the search for
solutions.
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